IP Library Granted Patent US 9,884,111
Granted Patent B2
US 9,884,111 · App. 13/577,787 · Granted Feb 6, 2018

Process for producing an allergen extract

Inventor: Jerónimo Carnés-Sánchez (Barcelona, ES)
Assignee: Laboratorios Leti, S.L.
A61K39/35C07K14/37C07K14/415C07K14/435C07K14/43531C07K14/47A61K2039/577
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,884,111
App. No.
13/577,787
Granted
Feb 6, 2018
Kind
B2
Abstract

The present invention discloses processes for producing native, depigmented and polymerized allergen extracts. The invention further discloses extracts produced via the processes, and pharmaceutical and vaccine compositions comprising the extracts, for diagnosis and treatment of allergy.

Claims (24)

1. A process for producing an allergen extract comprising:

a) contacting a source material comprising allergen with acetone to produce a mixture containing lipids dissolved in liquid phase and a solid phase consisting of source material residue comprising allergens and proteins,

b) subjecting the mixture to a first separation step to isolate the source material residue,

c) contacting the source material residue with an aqueous solution to produce a mixture of allergens dissolved in liquid phase, and a solid phase consisting of non-allergenic residue,

d) subjecting the mixture to a second separation step to isolate the allergens dissolved in liquid phase, to produce a crude allergen extract,

e) subjecting the crude allergen extract to a first low molecular fraction removal step to remove molecules having a molecular size of less than 3.5 kDa,

f) carrying out step e) until the crude allergen extract has conductivity of below 1000 μS/cm at 3-5° C. to obtain a purified native allergen extract, and

g) acidifying the purified native allergen extract to pH 2 to 4 to produce an acidified purified native allergen extract and maintaining the acidified purified native allergen extract for 5-30 minutes, followed by subjecting the acidified purified native allergen extract to a second low molecular fraction removal step to remove molecules having a molecular size of less than 3.5 kDa, and adjusting the pH to 7.0-8.0 to produce a depigmented allergen extract.

2. The process as claimed in claim 1 wherein step (f) comprises carrying out step e) until the crude allergen extract has conductivity of less than 500 μS/cm at 3-5° C.

3. The process as claimed in claim 1 wherein the purified native allergen extract is acidified to pH 2 to 2.1.

4. The process as claimed in claim 1 wherein the purified native allergen extract is acidified to pH 2.0 to 3.0.

5. The process as claimed in claim 1 , further comprising a polymerization step, comprising:

h) contacting the depigmented allergen extract with glutaraldehyde or formaldehyde to produce a crude depigmented polymerized allergen extract,

i) subjecting the crude depigmented polymerized allergen extract to a molecular fraction removal step to remove molecules having a molecular size of less than 100 kDa, and

j) carrying out step i) until the crude depigmented polymerized allergen extract has a conductivity of below 210 μS/cm at 3-5° C. and/or is absent of glutaraldehyde as determined by UV or visible scanning, to obtain a purified depigmented polymerized allergen extract.

6. The process as claimed in claim 1 , wherein the source material is selected from the group consisting of food allergens, peanuts, whole peanuts, air-borne allergens, dust mites, fungi, molds, mites, grasses, tree and weed allergens, epithelial allergens, and insect allergens.

7. The process as claimed in claim 5 , wherein the purified depigmented polymerized allergen extract is used in the treatment of an allergy.

8. A process according to claim 5 , wherein step (j) comprises carrying out step i) until the crude depigmented polymerized allergen extract has a conductivity between 50 and 200 μS/cm at 3-5° C.

9. A process according to claim 1 , wherein at least one of the first low molecular fraction removal step in step e) or the second low molecular fraction removal step in step g) comprises an ultrafiltration step, a diafiltration step, a dialysis step or filtration.

10. A process according to claim 6 , wherein the air-borne allergens are pollen, the epithelial allergens are animal hair or animal dander, and the insect allergens are allergens from cockroaches, fleas, bees or wasp venom.

11. A process according to claim 1 , wherein the source material is selected from the group consisting of food allergens, pollen, fungi and molds, epithelial allergens, and insect allergens.

12. A process according to claim 11 , wherein the food allergens are allergens from Arachis hypogaea , the pollen is from Alnus glutinosa, Betula alba, Corylus avellana, Cupressus arizonica, Olea europea, Platanus sp, Cynodon dactylon, Dactylis glomerata, Festuca elatior, Holcus lanatus, Lolium perenne, Phleum pratense, Phragmites communis, Poa pratensis, Ambrosia elatior, Artemisia vulgaris, Chenopodium album, Parietaria judaica, Plantago lanceolata, Salsola kali, Avena sativa, Hordeum vulgare, Secale cereal, Triticum aestivum, Zea mays ), dust mites ( Acarus siro, Blomia tropicalis, Dermatophagoides farinae, Dermatophagoides microceras, Dermatophagoides pteronyssinus, Euroglyphus maynei, Lepidoglyphus destructor, Tyrophagus putrescentiae , the fungi and molds are Alternaria alternate, Cladosporium herbarum , or Aspergillus fumigatus , the epithelias allergens are cat hair, cat dander, dog hair, dog dander, horse hair, horse dander, human hair, human dander, rabbit hair, rabbit dander, or feathers, and the insect allergens are from ants, fleas, mites, cockroaches, wasp venom, or bee venom.

13. A process according to claim 1 , wherein the source material is selected from the group consisting of Arachis hypogaea, Olea europaea pollen, Parietaria judaica pollen, Phragmites communis pollen, Phleum pratense pollen, Dermatophagoides pteronyssinus , and cat dander.

14. A process according to claim 1 , wherein the source material is Arachis hypogaea.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 058770 FRAME: 0916. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 2, 2022
From: LABORATORIOS LETI S.L.
To: LETI PHARMA, S.L
Reel/Frame 058950/0537 →
CHANGE OF NAME Recorded Jan 19, 2022
From: LABORATORIOS LETI, S.L.
To: LETI PHARMA, S.L.U.
Reel/Frame 058770/0916 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 028994 FRAME 0497. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 10, 2018
From: CARNES-SANCHEZ, JERONIMO
To: LABORATORIOS LETI, S.L. UNIPERSONAL
Reel/Frame 046113/0593 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2012
From: CARNES-SANCHEZ, JERONIMO
To: LABORATORIOS LETI, S.L.
Reel/Frame 028994/0497 →
Priority Claims (1)
ES 201030199 · Feb 12, 2010 · national
Continuity (1)
Related Publication 20150306211A1 · Oct 29, 2015